Portopulmonary hypertension (PoPH) affects a significant proportion of patients who undergo a liver transplant…
Articles by Ana Pena, PhD
A new procedure, performed at Northwestern Memorial Hospital in Illinois, successfully treated a patient…
A new study identified two potential therapeutic targets for pulmonary hypertension (PH) associated with heart…
Off-label use of pulmonary arterial hypertension (PAH) medications to treat patients with pulmonary hypertension…
Stimulating the activity of an immune system receptor called TLR3 led to a reduction of pulmonary hypertension…
Use of antidepressants during pregnancy doubles the risk for persistent pulmonary hypertension in the newborn (PPHN), a…
For patients with pulmonary hypertension (PH) who have undergone nonheart surgeries, self-reporting of walking and stair climbing…
The U.S. Food and Drug Administration has granted orphan drug designation to Livantra,…
Blood biomarkers may help to predict poor outcomes in babies born with a rare congenital defect of the diaphragm…
Adempas (riociguat), an approved therapy for adults with pulmonary hypertension (PH)…
Exercise has a wide range of benefits for people with pulmonary hypertension (PH), improving physical capacity and quality of…
Patients with pulmonary arterial hypertension (PAH) who can walk more than 400 meters (437 yards) on a six-minute…